Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes. (2021)
Attributed to:
Unravelling the Mechanism of the Lung Tumour Suppressor LIMD1 from Cellular Metabolism to Malignant Transformation.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41419-021-04355-7
PubMed Identifier: 34764236
Publication URI: http://europepmc.org/abstract/MED/34764236
Type: Journal Article/Review
Volume: 12
Parent Publication: Cell death & disease
Issue: 11